The first patient in the world to be enrolled on a clinical trial of a new investigational drug, AN0025, was treated at Huntsman Cancer Institute at the Ï㽶ÊÓƵ of Utah...
When Scott Vance went in for a COVID-19 test, he never expected it would lead to a diagnosis of stage IV lung cancer. Scott’s doctors learned a specific mutation was...
Researchers at Huntsman Cancer Institute at the Ï㽶ÊÓƵ of Utah presented the first outcomes evaluation of an adult oncology hospital-at-home program today at the 2020 American Society of Clinical Oncology...
Huntsman Cancer Institute celebrates International Women's Day 2018 in a conversation with Dr. Theresa Werner. Her patients juggle treatment with lives that often include work, a relationship, and motherhood. She...
Clinical trials at Huntsman Cancer Institute (HCI) help find better ways to prevent, diagnose, and treat cancer by testing the safety and effectiveness of new drugs and treatments. On average...
Huntsman Cancer Institute (HCI) has established The Society of Huntsman Translational Scholars, an initiative that recognizes excellence in the discipline of translational science. Translational researchers extend basic discoveries made in...
The Precision Exercise Prescription study is a unique collaboration between medical doctors, researchers, physical therapists, and patients. The study looks at how an exercise program tailored for each patient can...
HCI patient Clark Stringham felt like he was running out of time with his diagnosis of advanced prostate cancer. He credits a clinical trial and his oncologist, Neeraj Agarwal, MD...
In less than three years, HCI researchers have taken an idea from concept to lab to clinical evaluation. Conan Kinsey, MD, PhD, and Martin McMahon, PhD, combined two drugs that...
The American Society of Clinical Oncology recently published Clinical Cancer Advances, their 2019 annual report on the progress against cancer. The report examines the most transformative research of the past...
Ignacio Garrido-Laguna, MD, PhD, is a physician-scientist specializing in gastrointestinal cancers. A founding members of The Society of Huntsman Translational Scholars, he is honored to be selected as an awardee.
Howard Colman, MD, PhD, physician-scientist specializing in the treatment of brain tumors, was recognized by leaders at Huntsman Cancer Institute with a Huntsman Translational Scholar award.
